Associate Professor Jingxiu Bi

Associate Professor
  Org Unit School of Chemical Engineering
  Telephone +61 8 8313 4118
  Location Floor/Room 2 12 ,  Engineering North ,   North Terrace

Innovation technology in biomacromolecular modification and bioprocess design for vaccine development; Development of biodegradable targeted drug/gene delivery system; Vaccine formulation, storage and stability; Investigation of assembly process in peptides, virus like particles (VLP) proteins

2 PhD Scholarship positions in biomedical engineering open to international or domestic students are AVAILABLE for 2014 through University of Adelaide/Chinese Academy of Sciences Research Program!!! Please find the attached relevant information on the bottom.   

Book Chapter


  • Zeng A.-P., and Bi J-X., Chapter 9: Cell Culture Kinetics And Modeling. (2005). In: Cell Culture Technology for Pharmaceutical and Cellular Therapies. Eds S. S. Ozturk and W.-S. Hu . Marcel Dekker Inc. New York, p299-348;

Journal Publication


  • Du X., Shi B.Y., Liang J., Bi J.X., Dai S., Qiao S.Z., Developing Functionalized Dendrimer-like Silica Nanoparticles with Hierarchical Pores as Advanced Delivery?Nanocarriers, Advanced Materials, 2013, (accepted).
  • Shi B.Y., Hu Z., Dai S and Bi J.X., Qiao S.Z.(2013), Intracellular Microenvironment Responsive Polymer: A Multiple-stage Transport Platform for High-performance Gene Delivery, Small (accepted)
  • Shi B.Y., Hu Z., Dai S and Bi J.X., (2013); Developing a chitosan supported imidazole Schiff-base for high-efficiency gene delivery, Polymer Chemistry. 4(3):840-850;
  • Shi B.Y., Shen Z.Y., Hu Z., Dai S and Bi J.X., (2012); Exploring N-Imidazolyl-O-Carboxymethyl Chitosan for High Performance Gene Delivery, Biomacromolecules, 13(1): 146-53 ;
  • Shen Z.Y., Shi B.Y., Hu Z., Bi J.X., and Dai S., (2012); Exploring low-positively charged thermosensitive copolymers as gene delivery vectors, Soft Matter, 8(5): 1385-1394, 
  • Shi B.Y., Deng L., Xiaolin Shi X.L., Dai S., Hu Z., Bi J.X and Guo M.J., (2012); The enhancement of neural stem cell survival and growth by co-culturing with expanded sertoli cells in vitro, Biotechnology Progress, 28(1): 196®C205; 
  • Shen Z.Y, Li Y., Kohama K., Bi, J.X., (2011), Improved drug targeting of cancer cells by utilizing actively targetable folic acid-conjugated albumin nanospheres; Pharmacological Research, 63: 51®C58; 
  • Shen Z.Y., Wei W., Hideyuki T., Bi J.X., and Dai S., (2011), A galactosamine-mediated drug delivery carrier for targeted liver cancer therapy, Pharmacological Research, 64(4): 410-419; 
  • Zhang H., Dai S., Bi J.X. and Liu K.K, (2011), Biomimetic three-dimensional microenvironment for controlling stem cell fate, Interface Focus, 1(5):792-803;
  • Zhang Y., Luo J., Bi., J.X., Su Z.G.(2010). J. of Chromatography A, 1217: 3668®C3673;
  • Huang Y.D., Bi J.X., Su Z.G., (2010); Protein Expression and Purification 74 257®C263; 
  • Shi B-Y, Bi J-X., Guo M-J., Zhang S-L., (2010). Cell Proliferation 43, 275®C286; 
  • Lu Y., Wang L., Xue Y., Zhang C., Xing X.H., Lou K., Bi J.X, Su Z.G.(2009); Biochemical Engineering Journal, 43:135-141; 
  • Bi, J.X., Huang Y.D., Su Z.G., King K., Middelberg A., (2008), J. of Biotechnol., 136S(1):S645-S646; 
  • Wu T.; Huang Y.D.; Bi J.X.; Zhang Y.; Sun L. J.; Sun C.B.; Su Z.G.; (2008); Chinese Journal of Biotechnology, 24(7): 1279-1284;
  • Liu Y.H., Bi J.X., Zeng A.-P., Yuan J.Q. A cybernetic model to describe the dynamics of myeloma cell cultivations, Applied Mathematics and Computation,?2008, 205:84-97; 
  • Liu Y.H., Bi J.X., Zeng A.-P.,Yuan J.Q., A simple kinetic model for myeloma cell culture with consideration of lysine limitation, 2008, Bioprocess Biosyst Eng, 2008, 31(6): 569-577. 
  • Huang Y.D., Bi J.X., Zhou W.B., Su Z.G., et al. (2007), Protein Expression and Purification, 2007, 56: 301-310; 
  • Li Y., Bi, J.X., Y.D.Huang, Su Z.G. et al., (2007); Process Biochemistry, 42,315-319; 
  • Zhou W.B., Bi J.X., Li Y., Huang Y.D., Su Z.G., et al.,(2007).  Process Biochemistry, 42:751-756; 
  • Yu P.Z., Zhang G.F., Bi J.X., Su Z.G.,(2007) Process Biochemistry, 42: 971-977; 
  • Zheng, C., Bi, J.X., Ma, G., Su, Z.?; (2007), Blood Substitutes, and Biotechnology, 35 (6), pp. 568-584
  • Li R.H., Li Y., Bi J.X., Su Z.G., et al.(2007), Chinese Journal of Biotechnology, 423:692-699;
  • Zhou, F., Bi, J.X., Zeng, A.-P., Yuan, J. A macrokinetic model for myeloma cell culture based on stoichiometric balance. Biotechnology and Applied Biochemistry, 2007, 46 (2), pp. 85-95
  • Liu Y.H., Bi J.X., Zeng A.-P.,Yuan J.Q., A Population Balance Model Describing the Cell Cycle Dynamics of Myeloma Cell Cultivation, Biotechnol. Prog. 2007, 23, 1198-1209; 
  • Zhou W.B., Bi J.X., Janson J.C., Li Y., Huang Y.D., Zhang Y., Su Z.G., (2006), Journal of Chromatography B. 838, 71-77; 
  • 27. Huang Y.D., Bi J.X., Zhou W.B., Li Y., Wang Y., Ma G., Su Z.G., (2006). Process Biochemistry, 41:2320-2326 
  • Wang Y.M., Bi J.X. Zhao L., Zhou W.B., Li Y., Huang Y.D., Zhang Y., Lin H., Su Z.G.(2006), Chinese Journal of Biotechnology, 22, 278-284; 
  • Zhang Y., Bi J.X., Zhou W.B., Li Y., Dong A.H., Sun J., Su Z.G. (2006), The Chinese Journal of Proces Enginering, 6, 100-103; 
  • Zhou F., Bi J.X. Zeng A.-P., Yuan J.Q., A macrokinetic and regulator model for myeloma cell culture based on metabolic balance of pathways. Process of Biochemistry  2006, 41:2207-2217; 
  • Bi J.X., Janson J.C., Dong A.H., Li Y., Zhang Y., Huang Y.D., Su Z.G., (2005). Journal of Chromatography A, 1095, 119-125;
  • Zhi W.B., Song J.N., Ouyang F. and Bi J.X., (2005). Journal of  Biotechnology, 118, 157-165; 
  • Zhi W, Song J, Bi J.X, Ouyang F. (2005), Bioprocess and Biosystems Engineering. 27, 3-8 ; 
  • Yun Q., Yang R.E., Chen T., Bi J.X., Ma G.H., Su Z.G, (2005), Journal  of Biotechnology, 118, 67-74; 
  • Yun Q., Chen T., Zhang G. F., Bi J.X., Ma G.H., Su Z.G. (2005). Biotechnology Letters. 27, 213-217; 
  • Bi J.X., Zhou W.B., Li Y., Huang Y.D., Zhang Y., Dong A.H., Su Z.G., (2005), Chinese Journal of Biotechnology, 21, 947-953;
  • Li, X.N., Sun H.H., Zhang G.F., Bi J.X., Ma R.Y, Su Z.G., (2005). Journal of Seperation Science 28, 2363-9; 
  • Chen T., Yun Q., Bi. J.X., Ma G.H., Su Z.G., (2005),  Chinese Journal of Biotechnoly, 21, 284-288;
  • Zeng A.-P., and Bi J-X., Chapter 9: Cell culture kinetics and modeling. (2005). In: S. S. Ozturk and W.-S. Hu (eds.), Cell Culture Technology for Pharmaceutical and Cellular Therapies. Marcel Dekker Inc. New York, ISBN: 0-8247-5334-6. 
  • Bi J.-X, Shuttleworth J, Al-Rubeai M. (2004). Biotechnology and Bioengineering; 85, (7):741-749; 
  • 41. Ibarra N., Watanabe S., Bi J-X., Shuttleworth J., Al-Rubeai M. (2003). Biotechnology Progress, 19, 224-228; 
  • Bi J-X., Buhr P., Zeng A.-P., Wirth M., (2003), Human c-fos promoter mediates high-level, inducible expression in various mammalian cell lines, Biotechnol. Bioeng. 81:847-854.
  • Bi J.-X., Wirth M., Beer C., Zeng A.-P. (2002). Dynamic Characterization of Recombinant Chinese Hamster Ovary Cells Containing An Inducible c-fos Promoter GFP Expression System as a Biomarker, J. of Biotechnology, 93, 231-241; 

The information in this directory is provided to support the academic, administrative and business activities of the University of Adelaide. To facilitate these activities, entries in the University Phone Directory are not limited to University employees. The use of information provided here for any other purpose, including the sending of unsolicited commercial material via email or any other electronic format, is strictly prohibited. The University reserves the right to recover all costs incurred in the event of breach of this policy.

Entry last updated: Wednesday, 25 Mar 2015

To link to this page, please use the following URL: